UiPath (NYSE:PATH) Issues Earnings Results, Beats Expectations By $0.01 EPS

UiPath (NYSE:PATH) announced its quarterly earnings data on Thursday. The healthcare company reported $0.04 earnings per share for the quarter, beating analysts’ consensus estimates of $0.03 by $0.01, Briefing.com reports. The company had revenue of $316.00 million for the quarter, compared to analyst estimates of $303.69 million. UiPath had a negative return on equity of 2.97% and a negative net margin of 6.41%. The firm’s revenue for the quarter was up 10.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned ($0.09) EPS. UiPath updated its FY 2025 guidance to EPS and its Q3 2025 guidance to EPS.

UiPath Stock Up 0.2 %

PATH opened at $12.74 on Friday. The firm has a market cap of $7.30 billion, a P/E ratio of -79.63 and a beta of 0.87. The business’s fifty day simple moving average is $12.22 and its 200 day simple moving average is $16.80. UiPath has a 52 week low of $10.37 and a 52 week high of $27.87.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the company. Bank of America lifted their price target on UiPath from $16.00 to $18.00 and gave the company a “neutral” rating in a research note on Friday. KeyCorp restated a “sector weight” rating on shares of UiPath in a research report on Thursday, May 30th. Morgan Stanley cut their price target on shares of UiPath from $25.00 to $15.00 and set an “equal weight” rating for the company in a report on Thursday, May 30th. JPMorgan Chase & Co. decreased their price objective on shares of UiPath from $28.00 to $19.00 and set an “overweight” rating on the stock in a report on Thursday, May 30th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of UiPath in a report on Friday. Sixteen equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $18.12.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.